
1. virology. 2017 sep;509:90-97. doi: 10.1016/j.virol.2017.06.006. epub 2017 jun 16.

neuraminidase-based recombinant virus-like particles protect lethal avian
influenza a(h5n1) virus infection ferrets.

smith ge(1), sun x(2), bai y(2), liu yv(1), massare mj(1), pearce mb(2), belser
ja(2), maines tr(2), creager hm(3), glenn gm(1), flyer d(1), pushko p(4), levine 
mz(2), tumpey tm(5).

author information: 
(1)novavax, inc., 20 firstfield, gaithersburg, md 20878, usa.
(2)influenza division, national center immunization respiratory diseases,
centers disease control prevention, atlanta, ga, usa.
(3)influenza division, national center immunization respiratory diseases,
centers disease control prevention, atlanta, ga, usa; microbiology and
molecular genetics graduate program, emory university, atlanta, ga, usa.
(4)medigen, inc., 8420 gas house pike, frederick, md, usa.
(5)influenza division, national center immunization respiratory diseases,
centers disease control prevention, atlanta, ga, usa. electronic address:
ttumpey@cdc.gov.

avian influenza (h5n1) viruses represent growing threat influenza
pandemic. presence widespread avian influenza virus infections further
emphasizes need vaccine strategies control pre-pandemic h5n1 and
other avian influenza subtypes. influenza neuraminidase (na) vaccines represent a
potential strategy improving vaccines avian influenza h5n1 viruses.
to evaluate strategy na vaccination, generated recombinant influenza
virus-like particle (vlp) vaccine comprised na protein of
a/indonesia/05/2005 (h5n1) virus. ferrets vaccinated influenza n1 na vlps
elicited high-titer serum na-inhibition (ni) antibody titers protected
from lethal challenge a/indonesia/05/2005 virus. moreover, n1-immune ferrets
shed less infectious virus similarly challenged control animals. in
contrast, ferrets administered control n2 na vlps protected h5n1
virus challenge. results provide support continued development of
na-based vaccines influenza h5n1 viruses.

published elsevier inc.

doi: 10.1016/j.virol.2017.06.006 
pmcid: pmc5788299
pmid: 28624679  [indexed medline]

